ENTITY
Imugene Ltd

Imugene Ltd (IMU AU)

82
Analysis
Health Care • Australia
Imugene Limited is a health biotechnology development company. The Company manufactures vaccines for gastric and breast cancer treatments. Imugene operates in Europe and Australia.
more
bullish•Imugene Ltd
•21 Sep 2021 09:37

ASX100/​200 Index Rebalance Preview: Potential December Changes With Large Impact

There could be 1 change to the ASX100 and 5 changes to the ASX200 at the December rebalance. With a long M&A pipeline, there could be additional...

Logo
834 Views
Share
bullish•BYD Company
•19 Sep 2021 07:20

Index Rebalance & ETF Flow Recap: STO/OSH, KEP/SPH, HHI, SET50, HSTECH, HSCI

This recap highlights Insights covering the index rebalance space in Asia as well as announcements that could result in index changes. We also look...

Logo
659 Views
Share
bullish•Steadfast
•17 Aug 2021 18:58

ASX100/200/300 Index Rebalance Preview: Big Impact & Large Shorts

There are a lot of changes expected across the ASX100, 200 & 300 indices at the September rebalance. A lot of those stocks will have a large impact...

Logo
701 Views
Share
bullish•Imugene Ltd
•12 Aug 2021 12:56

ASX300 Sep 2021 Index Rebalance Preview: Changes Galore

There could be 8 adds and 5 deletes to the ASX300 index at the September rebalance. The stocks have moved but the index is not very widely tracked,...

Logo
1.3k Views
Share
bullish•Imugene Ltd
•16 Aug 2018 15:03•Issuer-paid

Imugene - Checkpoint inhibitor vaccine programme accelerated

Imugene has in-licenced a pipeline of B-cell vaccines that complements and advances its in-house programme. The deal has brought forward...

Share
x